Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- P/B of 0.85 — trading below book value
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -24.4%
- Revenue growing at 19% annually
CENTENE CORPORATION (CNC) is a Financial Services company operating in Hospital & Medical Service Plans, listed on the NYSE , with a market capitalisation of $16.9 billion . Key value metrics: P/B ratio 0.85, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
CENTENE CORPORATION — Fundamental Analysis Summary
On financial health, CNC shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -24.4% (sector average: 5.8%), and manageable leverage with a debt-to-equity ratio of 0.87.
StockPik's composite Value Score for CNC is 53/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
CNC reports a thin gross margin of 8.4% (sector average: 9.2%) and a negative operating margin of -2.8%.
CNC shows revenue growing at 19% year-over-year, with earnings declining at 302%.